[1]
Benatrehina, P.A.; Pan, L.; Naman, C.B.; Li, J.; Kinghorn, A.D. Usage, biological activity, and safety of selected botanical dietary supplements consumed in the United States. J. Tradit. Complement. Med., 2018, 8(2), 267-277.
[2]
Clarke, T.C.; Black, L.I.; Stussman, B.J.; Barnes, P.M.; Nahin, R.L. Trends in the use of complementary health approaches among adults: United States, 2002-2012. Natl. Health Stat. Rep., 2015, 2015(79), 1-16.
[3]
Bailey, R.L.; Gahche, J.J.; Miller, P.E.; Thomas, P.R.; Dwyer, J.T. Why US adults use dietary supplements. JAMA Intern. Med., 2013, 173(5), 355-361.
[4]
Brown, A.C. Kidney toxicity related to herbs and dietary
supplements: Online table of case reports. Part 3 of 5 series. Food
Chem. Toxicol, 2017, 107 (Pt A), 502-519.
[5]
Washington, A.E.; Lipstein, S.H. The patient-centered outcomes research institute promoting better information, decisions, and health. N. Engl. J. Med., 2011, 365(15), e31.
[6]
Dastjerdi, A.G.; Akhgari, M.; Kamali, A.; Mousavi, Z. Principal component analysis of synthetic adulterants in herbal supplements advertised as weight loss drugs. Complement. Ther. Clin. Pract., 2018, 31, 236-241.
[7]
Carrageta, D.F.; Dias, T.R.; Alves, M.G.; Oliveira, P.F.; Monteiro, M.P.; Silva, B.M. Anti-obesity potential of natural methylxanthines. J. Funct. Foods, 2018, 43, 84-94.
[8]
Yimam, M.; Jiao, P.; Hong, M.; Brownell, L.; Lee, Y.C.; Hyun, E.J.; Kim, H.J.; Kim, T.W.; Nam, J.B.; Kim, M-R. Evaluation of natural product compositions for appetite suppression. J. Diet. Suppl., 2019, 16(1), 86-104.
[9]
Saely, C.H.; Geiger, K.; Drexel, H. Brown versus white adipose tissue: A mini-review. Gerontology, 2012, 58(1), 15-23.
[10]
Hosseini, B.; Saedisomeolia, A.; Wood, L.G.; Yaseri, M.; Tavasoli, S. Effects of pomegranate extract supplementation on inflammation in overweight and obese individuals: A randomized controlled clinical trial. Complement. Ther. Clin. Pract., 2016, 22, 44-50.
[11]
Johnson, C.L.; Dohrmann, S.M.; Kerckove, V.; Diallo, M.S.; Clark, J.; Mohadjer, L.K.; Burt, V.L. National health and nutrition examination survey: National youth fitness survey estimation procedures, 2012. Vital Health Stat. 2, 2014, 2014(168), 1-25.
[12]
Cebi, N.; Yilmaz, M.T.; Sagdic, O.; Yuce, H.; Yelboga, E. Prediction of peroxide value in omega-3 rich microalgae oil by ATR-FTIR spectroscopy combined with chemometrics. Food Chem., 2017, 225, 188-196.
[13]
Rayalam, S.; Della-Fera, M.A.; Baile, C.A. Phytochemicals and regulation of the adipocyte life cycle. J. Nutr. Biochem., 2008, 19(11), 717-726.
[14]
Rodríguez, J.E.; Campbell, K.M. Past, present, and future of pharmacologic therapy in obesity. Prim. Care, 2016, 43(1), 61-67.
[15]
Zare, R.; Heshmati, F.; Fallahzadeh, H.; Nadjarzadeh, A. Effect of cumin powder on body composition and lipid profile in overweight and obese women. Complement. Ther. Clin. Pract., 2014, 20(4), 297-301.
[16]
Burke, F.M. Red yeast rice for the treatment of dyslipidemia. Curr. Atheroscler. Rep., 2015, 17(4), 495.
[17]
Langin, D. Adipose tissue lipolysis as a metabolic pathway to define pharmacological strategies against obesity and the metabolic syndrome. Pharmacol. Res., 2006, 53(6), 482-491.
[18]
Greenway, F.L. The safety and efficacy of pharmaceutical and herbal caffeine and ephedrine use as a weight loss agent. Obes. Rev., 2001, 2(3), 199-211.
[19]
Diepvens, K.; Westerterp, K.R.; Westerterp-Plantenga, M.S. Obesity and thermogenesis related to the consumption of caffeine, ephedrine, capsaicin, and green tea. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2007, 292(1), R77-R85.
[20]
Acheson, K.; Jéquier, E.; Wahren, J. Influence of beta-adrenergic blockade on glucose-induced thermogenesis in man. J. Clin. Invest., 1983, 72(3), 981-986.
[21]
Dulloo, A.G.; Duret, C.; Rohrer, D.; Girardier, L.; Mensi, N.; Fathi, M.; Chantre, P.; Vandermander, J. Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-H energy expenditure and fat oxidation in humans. Am. J. Clin. Nutr., 1999, 70(6), 1040-1045.
[22]
Yoshioka, M.; Lim, K.; Kikuzato, S.; Kiyonaga, A.; Tanaka, H.; Shindo, M.; Suzuki, M. Effects of red-pepper diet on the energy metabolism in men. J. Nutr. Sci. Vitaminol. (Tokyo), 1995, 41(6), 647-656.
[23]
Kawada, T.; Watanabe, T.; Takaishi, T.; Tanaka, T.; Iwai, K. Capsaicin-induced beta-adrenergic action on energy metabolism in rats: influence of capsaicin on oxygen consumption, the respiratory quotient, and substrate utilization. Proc. Soc. Exp. Biol. Med., 1986, 183(2), 250-256.
[24]
Borchardt, R.T.; Wu, Y.S. Potential inhibitors of s-adeno-sylmethionine-dependent methyltransferases. 3. modifications of the sugar portion of s-adenosylhomocysteine. J. Med. Chem., 1975, 18(3), 300-304.
[25]
Olah, M.E.; Stiles, G.L. Adenosine receptor subtypes: Characterization and therapeutic regulation. Annu. Rev. Pharmacol. Toxicol., 1995, 35(1), 581-606.
[26]
Trost, T.; Schwabe, U. Adenosine receptors in fat cells. identification by (-)-N6-[3H]phenylisopropyladenosine binding. Mol. Pharmacol., 1981, 19(2), 228-235.
[27]
Dhalla, A.K.; Chisholm, J.W.; Reaven, G.M.; Belardinelli, L. A1 adenosine receptor: Role in diabetes and obesity. Handb. Exp. Pharmacol., 2009, 2009(193), 271-295.
[28]
Vannucci, S.J.; Klim, C.M.; Martin, L.F.; LaNoue, K.F. A1-adenosine receptor-mediated inhibition of adipocyte adenylate cyclase and lipolysis in zucker rats. Am. J. Physiol. Metab., 1989, 257(6), E871-E878.
[29]
Fredholm, B.B.; Irenius, E.; Kull, B.; Schulte, G. Comparison of the potency of adenosine as an agonist at human adenosine receptors expressed in chinese hamster ovary cells. Biochem. Pharmacol., 2001, 61(4), 443-448.
[30]
Gnad, T.; Scheibler, S.; von Kügelgen, I.; Scheele, C.; Kilić, A.; Glöde, A.; Hoffmann, L.S.; Reverte-Salisa, L.; Horn, P.; Mutlu, S. Adenosine activates brown adipose tissue and recruits beige adipocytes via A2A receptors. Nature, 2014, 516(7531), 395-399.
[31]
Xie, Y.; Zhang, X.; Yang, J.; Kim, S.; Hong, S.; Giesy, J.P.; Yim, U.H.; Shim, W.J.; Yu, H.; Khim, J.S. eDNA-based bioassessment of coastal sediments impacted by an oil spill. Environ. Pollut., 2018, 238, 739-748.
[32]
Badshah, H.; Ullah, I.; Kim, S.E.; Kim, T.; Lee, H.Y.; Kim, M.O. Anthocyanins attenuate body weight gain via modulating neuropeptide Y and GABAB1 receptor in rats hypothalamus. Neuropeptides, 2013, 47(5), 347-353.
[33]
Tsuda, T.; Horio, F.; Uchida, K.; Aoki, H.; Osawa, T. Dietary cyanidin 3-O-Beta-D-Glucoside-rich purple corn color prevents obesity and ameliorates hyperglycemia in mice. J. Nutr., 2003, 133(7), 2125-2130.
[34]
Wu, T.; Yin, J.; Zhang, G.; Long, H.; Zheng, X. Mulberry and cherry anthocyanin consumption prevents oxidative stress and inflammation in diet-induced obese mice. Mol. Nutr. Food Res., 2016, 60(3), 687-694.
[35]
Avula, B.; Wang, Y.H.; Pawar, R.S.; Shukla, Y.J.; Schaneberg, B.; Khan, I.A. Determination of the appetite suppressant P57 in hoodia gordonii plant extracts and dietary supplements by liquid chromatography/electrospray ionization mass spectrometry (LC-MSD-TOF) and LC-UV methods. J. AOAC Int., 2006, 89(3), 606-611.
[36]
MacLean, D.B.; Luo, L.G. Increased ATP content/production in the hypothalamus may be a signal for energy-sensing of satiety: Studies of the anorectic mechanism of a plant steroidal glycoside. Brain Res., 2004, 1020(1-2), 1-11.
[37]
Klontz, K.C.; Timbo, B.B.; Street, D. Consumption of dietary supplements containing Citrus aurantium (Bitter Orange)-2004 California Behavioral Risk Factor Surveillance Survey (BRFSS). Ann. Pharmacother., 2006, 40(10), 1747-1751.
[38]
Kuriyan, R.; Raj, T.; Srinivas, S.K.; Vaz, M.; Rajendran, R.; Kurpad, A.V. Effect of Caralluma fimbriata extract on appetite, food intake and anthropometry in adult indian men and women. Appetite, 2007, 48(3), 338-344.
[39]
Wagner, J.D.; Cefalu, W.T.; Anthony, M.S.; Litwak, K.N.; Zhang, L.; Clarkson, T.B. Dietary soy protein and estrogen replacement therapy improve cardiovascular risk factors and decrease aortic cholesteryl ester content in ovariectomized cynomolgus monkeys. Metabolism, 1997, 46(6), 698-705.
[40]
Riccardi, G.; Rivellese, A.A. Effects of dietary fiber and carbohydrate on glucose and lipoprotein metabolism in diabetic patients. Diabetes Care, 1991, 14(12), 1115-1125.
[41]
Bo-Linn, G.W.; Santa Ana, C.A.; Morawski, S.G.; Fordtran, J.S. Starch blockers - Their effect on calorie absorption from a high-starch meal. N. Engl. J. Med., 1982, 307(23), 1413-1416.
[42]
Celleno, L.; Tolaini, M.V.; D’Amore, A.; Perricone, N.V.; Preuss, H.G. A dietary supplement containing standardized Phaseolus vulgaris extract influences body composition of overweight men and women. Int. J. Med. Sci., 2007, 4(1), 45-52.
[43]
Abidov, M.T.; Rio, M.J.; Ramazanov, T.Z.; Klimenov, A.L.; Dzhamirze, S.; Kalyuzhin, O.V. Effects of Aralia mandshurica and Engelhardtia chrysolepis extracts on some parameters of lipid metabolism in women with nondiabetic obesity. Bull. Exp. Biol. Med., 2006, 141(3), 343-346.
[44]
Moreno, L.A.; Tresaco, B.; Bueno, G.; Fleta, J.; Rodríguez, G.; Garagorri, J.M.; Bueno, M. Psyllium fibre and the metabolic control of obese children and adolescents. J. Physiol. Biochem., 2003, 59(3), 235-242.
[45]
Han, L.K.; Sumiyoshi, M.; Zhang, J.; Liu, M.X.; Zhang, X.F.; Zheng, Y.N.; Okuda, H.; Kimura, Y. Anti-obesity action Ofsalix matsudana leaves (Part 1). Anti-obesity action by polyphenols ofsalix matsudana in high fat-diet treated rodent animals. Phytother. Res., 2003, 17(10), 1188-1194.
[46]
Urizar, N.L.; Moore, D.D. GUGULIPID: A natural cholesterol-lowering agent. Annu. Rev. Nutr., 2003, 23(1), 303-313.
[47]
Vaskonen, T.; Mervaala, E.; Seppänen-Laakso, T.; Karppanen, H. Diet enrichment with calcium and magnesium enhances the cholesterol-lowering effect of plant sterols in obese zucker rats. Nutr. Metab. Cardiovasc. Dis., 2001, 11(3), 158-167.
[48]
Hirafuji, M.; Machida, T.; Hamaue, N.; Minami, M. cardiovascular protective effects of N-3 polyunsaturated fatty acids with special emphasis on docosahexaenoic acid. J. Pharmacol. Sci., 2003, 92(4), 308-316.
[49]
Lombardo, Y.B.; Chicco, A.G. Effects of dietary polyunsaturated N-3 fatty acids on dyslipidemia and insulin resistance in rodents and humans. A review. J. Nutr. Biochem., 2006, 17(1), 1-13.
[50]
Sato, D.; Kusunoki, M.; Seino, N.; Nishina, A.; Feng, Z.; Tsutsumi, K.; Nakamura, T. Black soybean extract reduces fatty acid contents in subcutaneous, but not in visceral adipose triglyceride in high-fat fed rats. Int. J. Food Sci. Nutr., 2015, 66(5), 539-545.
[51]
Park, C.H.; Kim, J.H.; Lee, E.B.; Hur, W.; Kwon, O.J.; Park, H.J.; Yoon, S.K. Aronia melanocarpa extract ameliorates hepatic lipid metabolism through PPARγ2 downregulation. PLoS One, 2017, 12(1), e0169685.
[52]
Su, S.H.; Shyu, H.W.; Yeh, Y.T.; Chen, K.M.; Yeh, H.; Su, S.J. Caffeine inhibits adipogenic differentiation of primary adipose-derived stem cells and bone marrow stromal cells. Toxicol. Vitr., 2013, 27(6), 1830-1837.
[53]
Aoyagi, R.; Funakoshi-Tago, M.; Fujiwara, Y.; Tamura, H. Coffee inhibits adipocyte differentiation via inactivation of PPARγ. Biol. Pharm. Bull., 2014, 37(11), 1820-1825.
[54]
Kim, Y.J.; Choi, M.S.; Cha, B.Y.; Woo, J.T.; Park, Y.B.; Kim, S.R.; Jung, U.J. Long-term supplementation of honokiol and magnolol ameliorates body fat accumulation, insulin resistance, and adipose inflammation in high-fat fed mice. Mol. Nutr. Food Res., 2013, 57(11), 1988-1998.
[55]
Parray, H.A.; Lone, J.; Park, J.P.; Choi, J.W.; Yun, J.W. Magnolol promotes thermogenesis and attenuates oxidative stress in 3T3-L1 adipocytes. Nutrition, 2018, 50, 82-90.
[56]
Yang, J.Y.; Anne Della-Fera, M.; Nelson-Dooley, C.; Baile, C.A.; Yang, A. Anne Della-fera, M.; Nelson-dooley, C. Cellular and molecular molecular mechanisms of apoptosis induced by ajoene in 3T3-L1 adipocytes. Obesity, 2006, 14(3), 388-397.
[57]
Kandulska, K.; Nogowski, L.; Szkudelski, T. Effect of some phytoestrogens on metabolism of rat adipocytes. Reprod. Nutr. Dev., 1999, 39(4), 497-501.
[58]
Szkudelska, K.; Szkudelski, T.; Nogowski, L. Daidzein, coumestrol and zearalenone affect lipogenesis and lipolysis in rat adipocytes. Phytomedicine, 2002, 9(4), 338-345.
[59]
Povolo, C.; Foschini, A.; Ribaudo, G. Optimization of the extraction of bioactive molecules from Lycium barbarum fruits and evaluation of the antioxidant activity: A combined study. Nat. Prod. Res., 2018, 1-5.
[60]
Kang, M.H.; Park, W.J.; Choi, M.K. Anti-obesity and hypolipidemic effects of Lycium chinense leaf powder in obese rats. J. Med. Food, 2010, 13(4), 801-807.
[61]
Amagase, H.; Nance, D.M. Lycium barbarum increases caloric expenditure and decreases waist circumference in healthy overweight men and women: Pilot study. J. Am. Coll. Nutr., 2011, 30(5), 304-309.
[62]
Yu, H.M.; Chung, H.K.; Kim, K.S.; Lee, J.M.; Hong, J.H.; Park, K.S. PDE 5 inhibitor improves insulin sensitivity by enhancing mitochondrial function in adipocytes. Biochem. Biophys. Res. Commun., 2017, 493(1), 631-636.
[63]
Ghofrani, H.A.; Osterloh, I.H.; Grimminger, F. Sildenafil: From Angina to erectile dysfunction to pulmonary hypertension and beyond. Nat. Rev. Drug Discov., 2006, 5(8), 689-702.
[64]
Ribaudo, G.; Pagano, M.A.; Bova, S.; Zagotto, G. New therapeutic applications of Phosphodiesterase 5 Inhibitors (PDE5-Is). Curr. Med. Chem., 2016, 23(12), 1239-1249.
[65]
Mitschke, M.M.; Hoffmann, L.S.; Gnad, T.; Scholz, D.; Kruithoff, K.; Mayer, P.; Haas, B.; Sassmann, A.; Pfeifer, A.; Kilic, A. Increased cGMP promotes healthy expansion and browning of white adipose tissue. FASEB J., 2013, 27(4), 1621-1630.
[66]
Ribaudo, G.; Pagano, M.A.; Pavan, V.; Redaelli, M.; Zorzan, M.; Pezzani, R.; Mucignat-Caretta, C.; Vendrame, T.; Bova, S.; Zagotto, G. Semi-synthetic derivatives of natural isoflavones from Maclura pomifera as a novel class of PDE-5A inhibitors. Fitoterapia, 2015, 105, 132-138.
[67]
Ribaudo, G.; Vendrame, T.; Bova, S. Isoflavones from Maclura pomifera : Structural elucidation and in silico evaluation of their interaction with PDE5. Nat. Prod. Res., 2017, 31(17), 1988-1994.
[68]
Pavan, V.; Mucignat-Caretta, C.; Redaelli, M.; Ribaudo, G.; Zagotto, G. The old made new: Natural compounds against erectile dysfunction. Arch. Pharm. (Weinheim), 2015, 348(9), 607-614.
[69]
Wu, C.; Rajagopalan, S. Phosphodiesterase-4 inhibition as a therapeutic strategy for metabolic disorders. Obes. Rev., 2016, 17(5), 429-441.
[70]
Arnold, R.; Beer, D.; Bhalay, G.; Baettig, U.; Collingwood, S.P.; Craig, S.; Devereux, N.; Dunstan, A.; Glen, A.; Gomez, S. 8-Aryl xanthines potent inhibitors of phosphodiesterase 5. Bioorg. Med. Chem. Lett., 2002, 12(18), 2587-2590.
[71]
Hachem, R.; Assemat, G.; Martins, N.; Balayssac, S.; Gilard, V.; Martino, R.; Malet-Martino, M. Proton NMR for detection, identification and quantification of adulterants in 160 herbal food supplements marketed for weight loss. J. Pharm. Biomed. Anal., 2016, 124, 34-47.
[72]
Neves, D.B.; Caldas, E.D. Determination of caffeine and identification of undeclared substances in dietary supplements and caffeine dietary exposure assessment. Food Chem. Toxicol., 2017, 105, 194-202.
[73]
Patel, D.N.; Li, L.; Kee, C.L.; Ge, X.; Low, M.Y.; Koh, H.L. Screening of synthetic PDE-5 inhibitors and their analogues as adulterants: Analytical techniques and challenges. J. Pharm. Biomed. Anal., 2014, 87, 176-190.
[74]
Kitka, T.; Tuza, S.; Varga, B.; Horváth, C.; Kovács, P. Differential regulation of metabolic parameters by energy deficit and hunger. Metabolism, 2015, 64(10), 1235-1239.
[75]
Carvalho, L.M.; Cohen, P.A.; Silva, C.V.; Moreira, A.P.L.; Falcão, T.M.; Dal Molin, T.R.; Zemolin, G.; Martini, M. A new approach to determining pharmacologic adulteration of herbal weight loss products. Food Addit. Contam. Part A, 2012, 29(11), 1661-1667.
Download PDF Flyer